Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Baxter
Express Scripts
Boehringer Ingelheim
Medtronic

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: OLAPARIB

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

OLAPARIB

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca Pharms LYNPARZA olaparib CAPSULE;ORAL 206162 NDA AstraZeneca Pharmaceuticals LP 0310-0657-58 112 CAPSULE in 1 BOTTLE (0310-0657-58)
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP 0310-0668-12 120 TABLET, FILM COATED in 1 BOTTLE (0310-0668-12)
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP 0310-0668-60 60 TABLET, FILM COATED in 1 BOTTLE (0310-0668-60)
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP 0310-0679-12 120 TABLET, FILM COATED in 1 BOTTLE (0310-0679-12)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
Johnson and Johnson
AstraZeneca
McKesson